(2R)-2-(1-cyclopropylpyrazol-4-yl)-4-[4-(2,4-difluorophenyl)-6,7-dimethylpyrido[2,3-d]pyrimidin-2-yl]-6-[[4-[7,7-dimethyl-2-[2-(1-methylpyrazol-4-yl)morpholin-4-yl]-8H-pyrido[2,3-d]pyrimidin-4-yl]-3-fluorophenyl]methyl]morpholine
C49H49F3N12O2 — CID 157044390
Data last refreshed: (MolForge compound catalog, from PubChem)
About (2R)-2-(1-cyclopropylpyrazol-4-yl)-4-[4-(2,4-difluorophenyl)-6,7-dimethylpyrido[2,3-d]pyrimidin-2-yl]-6-[[4-[7,7-dimethyl-2-[2-(1-methylpyrazol-4-yl)morpholin-4-yl]-8H-pyrido[2,3-d]pyrimidin-4-yl]-3-fluorophenyl]methyl]morpholine
(2R)-2-(1-cyclopropylpyrazol-4-yl)-4-[4-(2,4-difluorophenyl)-6,7-dimethylpyrido[2,3-d]pyrimidin-2-yl]-6-[[4-[7,7-dimethyl-2-[2-(1-methylpyrazol-4-yl)morpholin-4-yl]-8H-pyrido[2,3-d]pyrimidin-4-yl]-3-fluorophenyl]methyl]morpholine (PubChem CID 157044390) has the molecular formula C49H49F3N12O2 and a molecular weight of 895.01 g/mol. Its IUPAC name is (2R)-2-(1-cyclopropylpyrazol-4-yl)-4-[4-(2,4-difluorophenyl)-6,7-dimethylpyrido[2,3-d]pyrimidin-2-yl]-6-[[4-[7,7-dimethyl-2-[2-(1-methylpyrazol-4-yl)morpholin-4-yl]-8H-pyrido[2,3-d]pyrimidin-4-yl]-3-fluorophenyl]methyl]morpholine.
Molecular Properties
| Compound Name | (2R)-2-(1-cyclopropylpyrazol-4-yl)-4-[4-(2,4-difluorophenyl)-6,7-dimethylpyrido[2,3-d]pyrimidin-2-yl]-6-[[4-[7,7-dimethyl-2-[2-(1-methylpyrazol-4-yl)morpholin-4-yl]-8H-pyrido[2,3-d]pyrimidin-4-yl]-3-fluorophenyl]methyl]morpholine |
|---|---|
| PubChem CID | 157044390 |
| Molecular Formula | C49H49F3N12O2 |
| Molecular Weight | 895.01 g/mol |
| Exact Mass | 894.41 |
| IUPAC Name | (2R)-2-(1-cyclopropylpyrazol-4-yl)-4-[4-(2,4-difluorophenyl)-6,7-dimethylpyrido[2,3-d]pyrimidin-2-yl]-6-[[4-[7,7-dimethyl-2-[2-(1-methylpyrazol-4-yl)morpholin-4-yl]-8H-pyrido[2,3-d]pyrimidin-4-yl]-3-fluorophenyl]methyl]morpholine |
| SMILES | Cc1cc2c(-c3ccc(F)cc3F)nc(N3CC(Cc4ccc(-c5nc(N6CCOC(c7cnn(C)c7)C6)nc6c5C=CC(C)(C)N6)c(F)c4)O[C@H](c4cnn(C5CC5)c4)C3)nc2nc1C |
| InChI | InChI=1S/C49H49F3N12O2/c1-27-16-38-44(36-11-7-32(50)19-40(36)52)57-48(58-45(38)55-28(27)2)63-24-34(66-42(26-63)31-21-54-64(23-31)33-8-9-33)17-29-6-10-35(39(51)18-29)43-37-12-13-49(3,4)60-46(37)59-47(56-43)62-14-15-65-41(25-62)30-20-53-61(5)22-30/h6-7,10-13,16,18-23,33-34,41-42H,8-9,14-15,17,24-26H2,1-5H3,(H,56,59,60)/t34?,41?,42-/m0/s1 |
| InChIKey | DHDBFWVZEXMKNC-AAWJMGPTSA-N |
| XLogP | 8.43 |
| TPSA | 137.06 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 66 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 895.01 |
| LogP ≤ 5 | 8.43 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 14 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157044390 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.